Publications by authors named "Hartmut Link"

Claim this Profile
D
Digitalization and Standardization Oncology Drug Therapy Plans with the Onkopti Database for Online Publication and Import into Software.
Hartmut Link, Axel Wickenkamp, Annika Dresel, Migle Link, Cornelia Sibylle Link-Rachner, Hartmut Link

Oncology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining first-line treatment selection by combining clinical parameters: A post hoc analysis of the randomized open-label phase III trial FIRE-3/AIO KRK0306.
Julian Walter Holch, Alexander J Ohnmacht, Sebastian Stintzing, Kathrin Heinrich, Lena Weiss, Hartmut Link

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anemia diagnosis and therapy in malignant diseases: implementation of guidelines-a representative study.
Hartmut Link, Markus Kerkmann, Laura Holtmann, Markus Detzner

Support Care Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer.
Matti S Aapro, Stephen Chaplin, Paul Cornes, Sebastian Howe, Hartmut Link

Support Care Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Anemia: Diagnostics and Therapy].
Hans Tesch, Hans Tilman Steinmetz, Hartmut Link

Anasthesiol Intensivmed Notfallmed Schmerzther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3 / AIO KRK-0306.
Felix O Hofmann, Volker Heinemann, Melvin D'Anastasi, Alena B Gesenhues, Nina Hesse, Hartmut Link

Eur Radiol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Hartmut Link

Urologie· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative assessment of neutropenia events, healthcare resource use, and costs among cancer patients treated with lipegfilgrastim compared with pegfilgrastim in Germany.
Hartmut Link, Stephen F Thompson, Marc Tian, Jennifer S Haas, Dominic Meise

Support Care Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF).
Hartmut Link

Support Care Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections.
Hartmut Link, Markus Kerkmann, Laura Holtmann, ,

Support Care Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prophylaxis of nausea and vomiting after medical cancer treatment : Guidelines on supportive treatment-Part II].
Hartmut Link

Urologie· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[G-CSF for prophylaxis of neutropenia and febrile neutropenia, anemia in cancer : Guidelines on supportive treatment part 1].
Hartmut Link

Urologe A· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306).
Lian Liu, Nicole Tonya Erickson, Ingrid Ricard, Ludwig Fischer von Weikersthal, Markus M Lerch, Hartmut Link

Int J Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial.
Christoph Röllig, Hubert Serve, Richard Noppeney, Maher Hanoun, Utz Krug, Hartmut Link

Leukemia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
Hartmut Link, G Illerhaus, U M Martens, A Salar, R Depenbusch

Support Care Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in Germany.
Hartmut Link, Ingo Diel, Carsten-H Ohlmann, Laura Holtmann, Markus Kerkmann

Support Care Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial.
Laura Cicconi, Uwe Platzbecker, Giuseppe Avvisati, Francesca Paoloni, Christian Thiede, Hartmut Link

Leukemia· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Markus Moehler, Salah-Edin Al-Batran, Tilo Andus, Jann Arends, Dirk Arnold, Hartmut Link

Z Gastroenterol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo-filgrastim, short-acting recombinant human granulocyte colony-stimulating factors.
Camille N Abboud, Nicole Lang, Henry Fung, Andreas Lammerich, Anton Buchner, Hartmut Link

Support Care Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
Christian Michel, Andreas Burchert, Andreas Hochhaus, Susanne Saussele, Andreas Neubauer, Hartmut Link

Haematologica· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G-CSF guideline adherence in Germany, an update with a retrospective and representative sample survey.
Hartmut Link, Markus Kerkmann, Laura Holtmann, Petra Ortner,

Support Care Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic Growth Factors in the Management of Anemia and Febrile Neutropenia.
Hartmut Link

Breast Care (Basel)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer.
Achim Wöckel, Jasmin Festl, Tanja Stüber, Katharina Brust, Mathias Krockenberger, Hartmut Link

Geburtshilfe Frauenheilkd· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer.
Achim Wöckel, Jasmin Festl, Tanja Stüber, Katharina Brust, Stephanie Stangl, Hartmut Link

Geburtshilfe Frauenheilkd· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
Julian Walter Holch, Ingrid Ricard, Sebastian Stintzing, Ludwig Fischer von Weikersthal, Thomas Decker, Hartmut Link

Int J Cancer· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis